Kar-Fu Yeung1, Mihir Gandhi1,2,3, Amanda Yun Rui Lam4,5, Selly Julianty5,6, Alvin Yeow Meng Chia5, Gilbert Choon Seng Tan5,7, Su-Yen Goh4,5, Emily Tse Lin Ho4,6, Angela Fang Yung Koh5,8, Gavin Siew Wei Tan5,9, Eugene Jin Wen Shum6, Eric A Finkelstein10, Tazeen H Jafar10, Yee Leong Teoh2, Rob M van Dam11, Clare Whitton11, Julian Thumboo12, Yong Mong Bee13,14. 1. Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore. 2. Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore. 3. The Center for Child Health Research, Tampere University, Tampere, Finland. 4. Department of Endocrinology, Singapore General Hospital, Singapore, Singapore. 5. SingHealth Duke-NUS Diabetes Centre, Singapore, Singapore. 6. Regional Health System Office, SingHealth, Singapore, Singapore. 7. SingHealth Polyclinics, Singapore, Singapore. 8. Department of Internal Medicine, Sengkang General Hospital, Singapore, Singapore. 9. Surgical Retinal Department, Singapore National Eye Centre, Singapore, Singapore. 10. Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore. 11. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. 12. Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore. 13. Department of Endocrinology, Singapore General Hospital, Singapore, Singapore. bee.yong.mong@singhealth.com.sg. 14. SingHealth Duke-NUS Diabetes Centre, Singapore, Singapore. bee.yong.mong@singhealth.com.sg.
Abstract
BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. METHODS: This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. DISCUSSION: The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. TRIAL REGISTRATION: ClinicalTrials.gov NCT03503942 . Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019.
RCT Entities:
BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. METHODS: This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. DISCUSSION: The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. TRIAL REGISTRATION: ClinicalTrials.gov NCT03503942 . Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019.
Authors: Cheryl L Graffagnino; James M Falko; Michelle La Londe; Joann Schaumburg; Michael F Hyek; Lynn E T Shaffer; Richard Snow; Teresa Caulin-Glaser Journal: Obesity (Silver Spring) Date: 2006-02 Impact factor: 5.002
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245
Authors: M Kaye Kramer; Andrea M Kriska; Elizabeth M Venditti; Rachel G Miller; Maria M Brooks; Lora E Burke; Linda M Siminerio; Francis X Solano; Trevor J Orchard Journal: Am J Prev Med Date: 2009-12 Impact factor: 5.043
Authors: Mary Beth Weber; Harish Ranjani; Lisa R Staimez; Ranjit M Anjana; Mohammed K Ali; K M Venkat Narayan; Viswanathan Mohan Journal: Diabetes Care Date: 2016-08-08 Impact factor: 19.112
Authors: Kar-Fu Yeung; Yu Qi Lee; Mary Foong Fong Chong; Mihir Gandhi; Amanda Yun Rui Lam; Selly Julianty; Gilbert Choon Seng Tan; Emily Tse Lin Ho; Su-Yen Goh; Gavin Siew Wei Tan; Eugene Jin Wen Shum; Eric A Finkelstein; Tazeen H Jafar; Rob M van Dam; Yee Leong Teoh; Julian Thumboo; Yong Mong Bee Journal: BMJ Open Diabetes Res Care Date: 2022-10